Editorial Board — Medscape Business of Medicine
Board Members
- Judith N. Aburmishan, MBA, CPA, CHBC
- A & A Accounting and Business Consulting
Des Plains, Illinois
- A & A Accounting and Business Consulting
- Arthur L. Caplan, PhD
- New York University Langone Medical Center
New York, New York
- New York University Langone Medical Center
- Gregory A. Hood, MD
- University of Kentucky School of Medicine
Drs. Borders, Hood & Associates
Lexington, Kentucky
- University of Kentucky School of Medicine
- Kathryn I. Moghadas, RN, CHBC
- Associated Health Care Advisors
Winter Springs, Florida
- Associated Health Care Advisors
- Robert C. Scroggins, JD
- ScrogginsGrear, Inc.
Cincinnati, Ohio
- ScrogginsGrear, Inc.
- Ronald B. Sterling, MBA
- President, Sterling Solutions
- Elizabeth W. Woodcock, MBA
- Emory University Rollins School of Public Health
Atlanta, Georgia
- Emory University Rollins School of Public Health
Board Member Details
Judith N. Aburmishan, MBA, BS
Managing Director, A & A Accounting and Business Consulting, Des Plains, Illinois
Judith N. Aburmishan, MBA, CPA, CHBC, has disclosed no relevant financial relationships.
Arthur L. Caplan, PhD
Drs. William F. and Virginia Connolly Mitty Chair; Director, Division of Medical Ethics, Department of Population Health, NYU Robert I. Grossman School of Medicine, New York, NY
Arthur L. Caplan, PhD, has disclosed the following relevant relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: WIRB-Copernicus Group; BioMarin Pharmaceutical Inc.; CSL; GlaxoSmithKline; Fox Chase Cancer Center; Abeona; Genae/Cardialen Inc (Data and Safety Monitoring Board); Parker Waichman LLP; Nelson Mullins Riley & Scarborough LLP; Otsuka Pharmaceutical Co., Ltd.; Cabaletta Bio
Compensated for a lecture by: Pfizer Inc
Serves as the unpaid chair of the Compassionate Use Advisory Committees (CompAC), independent panels of internationally recognized medical experts, bioethicists, and patient representatives formed by NYU School of Medicine in collaboration with Janssen. CompAC advises Janssen about requests for compassionate use of its investigational medicines. NYU receives administrative funding from Janssen to facilitate the CompAC committees.
Has consulted for Sangamo Therapeutics, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; sanofi-aventis; Novartis Pharmaceuticals Corporation (all compassionate use; unpaid); Foundation for the National Institutes of Health (unpaid)
Gregory A. Hood, MD
Assistant Professor, Department of Internal Medicine, University of Kentucky; Drs. Borders, Hood & Associates, Lexington, Kentucky
Gregory A. Hood, MD, has disclosed no relevant financial relationships.
Kathryn I. Moghadas, RN, CIRM, CHBC, CPCO, CPC
Practice Management Consultant; President, Associated Health Care Advisors, Winter Springs, Florida
Kathryn I. Moghadas, RN, CIRM, CHBC, CPCO, CPC, has disclosed no relevant financial relationships.
Robert C. Scroggins, JD, CPA, CHBC
Principal and Management Consultant, ScrogginsGrear, Inc., Cincinnati, Ohio
Robert C. Scroggins, JD, CPA, CHBC, has disclosed no relevant financial relationships.
Ronald B. Sterling, MBA
President, Sterling Solutions, Silver Spring, Maryland
Ronald B. Sterling, MBA, has disclosed the following relevant relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Prism Health
Have a 5% or greater equity from: Prism Health
Elizabeth W. Woodcock, MBA
Adjunct Assistant Professor, Emory University Rollins School of Public Health, Atlanta, Georgia
Elizabeth Woodcock, MBA, has disclosed no relevant financial relationships.